TGFß1/Smad3 counteracts BRCA1-dependent repair of DNA damage

被引:55
作者
Dubrovska, A
Kanamoto, T
Lomnytska, M
Heldin, CH
Volodko, N
Souchelnytskyi, S
机构
[1] Ludwig Inst Canc Res, Biomed Ctr, SE-75124 Uppsala, Sweden
[2] Hiroshima Univ, Dept Ophthalmol & Visual Sci, Grad Sch Biomed Sci, Minami Ku, Hiroshima 7348551, Japan
[3] Lviv Natl Med Univ, Dept Oncol & Med Radiol, UA-79031 Lvov, Ukraine
关键词
Smad3; BRCA1; transforming growth factor-ss; DNA repair; breast cancer;
D O I
10.1038/sj.onc.1208443
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inactivation of the BRCA1 gene has been found to confer susceptibility to early-onset familial breast and ovarian cancers. BRCA1 regulates DNA repair, chromatin remodeling and affects gene transcription. Transforming growth factor-beta (TGF beta) is a potent regulator of growth, apoptosis and invasiveness of tumor cells, including breast cancer cells. Here we show that Smad3 which is a component of the TGF beta signaling pathway, forms a complex with BRCA1 in vitro and in vivo. The interaction is mediated by the MH1 domain of Smad3 and the G terminal part of BRCA1. We observed a co-localization of Smad3 and BRCA1 in nuclear complexes. We also found that TGF beta 1/Smad3 counteracted BRCA1-dependent repair of DNA double-strand breaks in human breast epithelial cells, as evaluated by BRCA1 nuclear foci formation, single-cell gel electrophoresis and cell survival assays. Thus, TGF beta 1/Smad3 suppresses BRCA1-dependent DNA repair in response to a DNA damaging agent.
引用
收藏
页码:2289 / 2297
页数:9
相关论文
共 30 条
[1]   SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer [J].
Boulay, JL ;
Mild, G ;
Lowy, A ;
Reuter, J ;
Lagrange, M ;
Terracciano, L ;
Laffer, U ;
Herrmann, R ;
Rochlitz, C .
BRITISH JOURNAL OF CANCER, 2002, 87 (06) :630-634
[2]   Role of transforming growth factor-β signaling in cancer [J].
de Caestecker, MP ;
Piek, E ;
Roberts, AB .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (17) :1388-1402
[3]   Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene [J].
Dennler, S ;
Itoh, S ;
Vivien, D ;
ten Dijke, P ;
Huet, S ;
Gauthier, JM .
EMBO JOURNAL, 1998, 17 (11) :3091-3100
[4]   TGF-β signaling in tumor suppression and cancer progression [J].
Derynck, R ;
Akhurst, RJ ;
Balmain, A .
NATURE GENETICS, 2001, 29 (02) :117-129
[5]   Smad-dependent and Smad-independent pathways in TGF-β family signalling [J].
Derynck, R ;
Zhang, YE .
NATURE, 2003, 425 (6958) :577-584
[6]  
Ewan KB, 2002, CANCER RES, V62, P5627
[7]   Defects in transforming growth factor-β signaling cooperate with a Ras oncogene to cause vapid aneuploidy and malignant transformation of mouse keratinocytes [J].
Glick, A ;
Popescu, N ;
Alexander, V ;
Ueno, H ;
Bottinger, E ;
Yuspa, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (26) :14949-14954
[8]   Functional proteomics of transforming growth Factor-β1-stimulated Mv1Lu epithelial cells:: Rad51 as a target of TGFβ1-dependent regulation of DNA repair [J].
Kanamoto, T ;
Hellman, U ;
Heldin, CH ;
Souchelnytskyi, S .
EMBO JOURNAL, 2002, 21 (05) :1219-1230
[9]   Cancer-susceptibility genes - Gatekeepers and caretakers [J].
Kinzler, KW ;
Vogelstein, B .
NATURE, 1997, 386 (6627) :761-&
[10]   A mechanism of repression of TGFβ/Smad signaling by oncogenic Ras [J].
Kretzschmar, M ;
Doody, J ;
Timokhina, I ;
Massagué, J .
GENES & DEVELOPMENT, 1999, 13 (07) :804-816